JPET

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Journal of Pharmacology And Experimental Therapeutics Fast Forward
First published on October 14, 2003; DOI: 10.1124/jpet.103.055392


0022-3565/03/3073-1163-1170$20.00
JPET 307:1163-1170, 2003
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jpet.103.055392v1
307/3/1163    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kell, P. J.
Right arrow Articles by McHowat, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kell, P. J.
Right arrow Articles by McHowat, J.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*CHOLINE BITARTRATE
*CHOLINE CHLORIDE

CARDIOVASCULAR

Inhibition of Platelet-Activating Factor (PAF) Acetylhydrolase by Methyl Arachidonyl Fluorophosphonate Potentiates PAF Synthesis in Thrombin-Stimulated Human Coronary Artery Endothelial Cells

Pamela J. Kell, Michael H. Creer, Kimberley N. Crown, Karin Wirsig, and Jane McHowat

Department of Pathology, St. Louis University School of Medicine, St. Louis, Missouri

We have previously demonstrated that thrombin stimulation of endothelial cells results in increased membrane-associated, Ca2+-independent phospholipase A2 (iPLA2) activity, accelerated hydrolysis of membrane plasmalogen phospholipids, and production of several biologically active phospholipid metabolites, including prostacyclin and platelet-activating factor (PAF) that is abolished by pretreatment with the iPLA2-selective inhibitor bromoenol lactone. This study was designed to further investigate the role of alternative PLA2 inhibitors, including methyl arachidonyl fluorophosphonate (MAFP, an inhibitor of cytosolic PLA2 isoforms), on phospholipid turnover and PAF production from thrombin-stimulated human coronary artery endothelial cells (HCAECs). Paradoxically, pretreatment of HCAEC with MAFP (5–25 µM) resulted in a significant increase in PAF production in both unstimulated and thrombin-stimulated cells that was found to be a direct result of inhibition of PAF acetylhydrolase (PAF-AH) activity. Pretreatment with MAFP did not significantly inhibit HCAEC PLA2 activity, possibly due to the localization of PLA2 activity in the membrane fraction rather than the cytosol. Bromoenol lactone did not inhibit PAF-AH activity, even at concentrations as high as 20 µM. We conclude that MAFP augments thrombin-stimulated PAF production by inhibition of PAF catabolism without affecting membrane-associated iPLA2 activity.


Received June 5, 2003; accepted September 5, 2003.

Address correspondence to: Dr. Jane McHowat, Department of Pathology, St. Louis University School of Medicine, 1402 S. Grand Blvd., St. Louis, MO 63104. E-mail: mchowatj{at}slucare1.sluh.edu




This article has been cited by other articles:


Home page
J. Lipid Res.Home page
J. Chen, L. Yang, J. M. Foulks, A. S. Weyrich, G. K. Marathe, and T. M. McIntyre
Intracellular PAF catabolism by PAF acetylhydrolase counteracts continual PAF synthesis
J. Lipid Res., November 1, 2007; 48(11): 2365 - 2376.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
G. R. Kinsey, J. McHowat, C. S. Beckett, and R. G. Schnellmann
Identification of calcium-independent phospholipase A2{gamma} in mitochondria and its role in mitochondrial oxidative stress
Am J Physiol Renal Physiol, February 1, 2007; 292(2): F853 - F860.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
T. Kriska, G. K. Marathe, J. C. Schmidt, T. M. McIntyre, and A. W. Girotti
Phospholipase Action of Platelet-activating Factor Acetylhydrolase, but Not Paraoxonase-1, on Long Fatty Acyl Chain Phospholipid Hydroperoxides
J. Biol. Chem., January 5, 2007; 282(1): 100 - 108.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
M. C. Meyer and J. McHowat
Calcium-independent phospholipase A2-catalyzed plasmalogen hydrolysis in hypoxic human coronary artery endothelial cells
Am J Physiol Cell Physiol, January 1, 2007; 292(1): C251 - C258.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
U. A. Kessen, R. H. Schaloske, D. L. Stephens, K. Killermann Lucas, and E. A. Dennis
PGE2 release is independent of upregulation of Group V phospholipase A2 during long-term stimulation of P388D1 cells with LPS
J. Lipid Res., November 1, 2005; 46(11): 2488 - 2496.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
S. M. Vinson, A. Rickard, J. S. Ryerse, and J. McHowat
Neutrophil Adherence to Bladder Microvascular Endothelial Cells following Platelet-Activating Factor Acetylhydrolase Inhibition
J. Pharmacol. Exp. Ther., September 1, 2005; 314(3): 1241 - 1247.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
A. Rickard, C. Portell, P. J. Kell, S. M. Vinson, and J. McHowat
Protease-activated receptor stimulation activates a Ca2+-independent phospholipase A2 in bladder microvascular endothelial cells
Am J Physiol Renal Physiol, April 1, 2005; 288(4): F714 - F721.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
M. C. Meyer, P. J. Kell, M. H. Creer, and J. McHowat
Calcium-independent phospholipase A2 is regulated by a novel protein kinase C in human coronary artery endothelial cells
Am J Physiol Cell Physiol, February 1, 2005; 288(2): C475 - C482.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2003 by the American Society for Pharmacology and Experimental Therapeutics.